DOD-CDMRP: Prostate Cancer Research Program - Synergistic Idea Development Award

Supports new or existing partnerships between two or three independent investigators to address a central innovative question or problem in PC that may include high risk, provided there is a potential for significant impact. Emphasis is on Synergy, Innovation, and Impact. Funding $750K over 3 years.

All applications for PCRP funding opportunities should also address at least one of 6 PCRP focus areas:
 - Biomarkers: Discovery and validation of biomarkers for the detection, prediction of response to therapy, prognosis,  and progression of PC.
 - Genetics: Understanding the genetics and epigenetics responsible for susceptibility, disease progression, and  treatment outcomes for clinically significant PC.
 - Imaging: Development of new anatomic and molecular imaging technology for the detection and management of PC.
 - Survivorship: Studies on the impact of treatment, nutrition, metabolism, and exercise on the well-being of PC patients and their families.
 - Therapy: Identification of new targets, pathways, and therapeutic modalities, including immunotherapy and mechanisms of resistance.
 - Tumor Biology and Immunology: Understanding prognosis and progression of PC.

Each PCRP funding opportunity either requires or encourages applications to address one of the following PCRPoverarching challenges:
- Develop effective treatments for advanced PC (i.e. disease relapse with no available curative therapy);
- Distinguish aggressive from indolent disease.